Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Murali Mohan Bhandi"'
Autor:
Amrita Kadari, Sagarika Gudem, Hitesh Kulhari, Murali Mohan Bhandi, Roshan M. Borkar, Venkata Ramana Murthy Kolapalli, Ramakrishna Sistla
Publikováno v:
Drug Delivery, Vol 24, Iss 1, Pp 224-232 (2017)
Fisetin (FST), a potent anticancer phytoconstituent, exhibits poor aqueous solubility and hence poor bioavailability. The aim of the present study is to improve the oral bioavailability of FST by encapsulating into PLGA NPs (poly-lactide-co-glycolic
Externí odkaz:
https://doaj.org/article/a0431b8071df454495c3ca95f48956a6
Publikováno v:
Bioresource Technology. 382:129031
Autor:
Narendra Kumar Nagendla, Kathirvel Muralidharan, Malothu Raju, Mohan Harshvardhan, Piramanayagam Selvakumar, Murali Mohan Bhandi, Mohana Krishna Reddy Mudiam, Vaikundamoorthy Ramalingam
Publikováno v:
Food Research International. :112993
Autor:
Murali Mohan Bhandi, R. Srinivas, Kotamarthi Bhanuprakash, M. Ananth Reddy, C. Purna Chander, A. Ramesh Babu, V. Jayathirtha Rao, M. V. Niladari Raju, G. Raju
Publikováno v:
Rapid Communications in Mass Spectrometry. 31:469-474
Autor:
Abhay T. Sangamwar, Roshan M. Borkar, Sanjay K. Banerjee, R. Srinivas, V. Ganga Reddy, Ahmed Kamal, Murali Mohan Bhandi, Ajay P. Dubey, Prashanth Komirishetty, Prajwal P. Nandekar
Publikováno v:
Biomedical Chromatography. 30:1556-1572
The aim of the present study was to evaluate the contribution of metabolites to drug-drug interaction and drug-herb interaction using the inhibition of CYP2D6 and CYP3A4 by metoprolol (MET) and its metabolites. The peak concentrations of unbound plas
Publikováno v:
RSC Advances. 6:10719-10735
Rabeprazole, an antiulcer drug in the class of proton pump inhibitors was subjected to force degradation studies as per ICH guidelines Q1A (R2). The chromatographic separation of the drug and its degradation products were achieved on a Purospher STAR
Autor:
Ajay P. Dubey, Abhay T. Sangamwar, R. Srinivas, Murali Mohan Bhandi, Sanjay K. Banerjee, Roshan M. Borkar, Prajwal P. Nandekar
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis. 102:386-399
Fidarestat, an aldose reductase inhibitor, has been used for the treatment of the diabetic associated complications such as retinopathy, neuropathy and nephropathy. To better understand the metabolism and pharmacokinetics of fidarestat, we have evalu
Autor:
Ramakrishna Sistla, Hitesh Kulhari, Roshan M. Borkar, Sagarika Gudem, Venkata Ramana Murthy Kolapalli, Murali Mohan Bhandi, Amrita Kadari
Publikováno v:
Drug Delivery, Vol 24, Iss 1, Pp 224-232 (2017)
Drug Delivery
article-version (VoR) Version of Record
Drug Delivery
article-version (VoR) Version of Record
Fisetin (FST), a potent anticancer phytoconstituent, exhibits poor aqueous solubility and hence poor bioavailability. The aim of the present study is to improve the oral bioavailability of FST by encapsulating into PLGA NPs (poly-lactide-co-glycolic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd61336987afb24338599615f4540085
Autor:
P. Naveen Chander Reddy, Murali Mohan Bhandi, Ramu Adela, Roshan M. Borkar, Sanjay K. Banerjee, R. Srinivas, Gayatri Vishwakarma
Publikováno v:
Scientific Reports
The purpose of the present study was to measure six vitamin D metabolites and to find the association between vitamin D deficiency and coronary artery diseases in diabetes (T2DM_CAD). Four groups [control (n = 50), type 2 diabetes (T2DM, n = 71), cor
Autor:
Roshan M, Borkar, Murali Mohan, Bhandi, Ajay P, Dubey, V, Ganga Reddy, Prashanth, Komirishetty, Prajwal P, Nandekar, Abhay T, Sangamwar, Ahmed, Kamal, Sanjay K, Banerjee, R, Srinivas
Publikováno v:
Biomedical chromatography : BMC. 30(10)
The aim of the present study was to evaluate the contribution of metabolites to drug-drug interaction and drug-herb interaction using the inhibition of CYP2D6 and CYP3A4 by metoprolol (MET) and its metabolites. The peak concentrations of unbound plas